securities 132,046 133,450
Total assets $340,967 $286,174
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Deferred revenues $142,096 $114,069
Accounts payable and accrued liabilities 24,611 18,721
Accrued incentive compensation 10,069 10,608
Total current liabilities 176,776 143,398
Long-term deferred revenues 10,187 2,925
Other long-term liabilities 1,528 1,387
Total liabilities 188,491 147,710
Stockholders' equity:
Common stock 214 208
Additional paid-in capital 210,027 181,380
Retained earnings 104,491 80,962
Accumulated elements of comprehensive
income 472 (1,156)
Treasury stock (162,728) (122,930)
Total stockholders' equity 152,476 138,464
Total liabilities and stockholders'
equity $340,967 $286,174
THE ADVISORY BOARD COMPANY
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Nine Months Ended December 31,
2007 2006
Cash flows from operating activities:
Net income $23,529 $20,217
Adjustments to reconcile net income
to net cash provided by
'/>"/>SOURCE The Advisory Board Company Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Related medicine news :1.
Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board2.
Dr. Warren Jackman Joins CryoCor Scientific Advisory Board3.
OSHA Seeking Nominations for National Advisory Committee on Occupational Safety and Health4.
National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council5.
Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available6.
The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 20087.
Statement from the Consumer Healthcare Products Association on Todays FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Oral Dose8.
American Society for Aesthetic Plastic Surgery and American Society of Plastic Surgeons Offer Patient Advisory for those Affected by Fig LipoDissolve Closures9.
FDA Advisory Panel Finds Hologics Adiana(R) Permanent Contraception Approvable10.
Bradmer announces additions to Scientific Advisory Board11.
Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board